News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,324 Results
Type
Article (13621)
Company Profile (109)
Press Release (248594)
Section
Business (87999)
Career Advice (464)
Deals (15334)
Drug Delivery (64)
Drug Development (36610)
Employer Resources (49)
FDA (6266)
Job Trends (6187)
News (150168)
Policy (14014)
Tag
Academia (436)
Alliances (23154)
Alzheimer's disease (362)
Approvals (6276)
Artificial intelligence (66)
Bankruptcy (143)
Best Places to Work (4348)
Biotechnology (44)
Breast cancer (61)
Cancer (405)
Career advice (406)
Cell therapy (56)
Clinical research (30606)
Collaboration (194)
Compensation (81)
COVID-19 (748)
C-suite (58)
Data (429)
Diabetes (63)
Diagnostics (1241)
Drug discovery (43)
Drug pricing (59)
Earnings (31604)
Employer resources (43)
Events (36950)
Executive appointments (217)
FDA (6500)
Funding (131)
Gene therapy (62)
GLP-1 (302)
Government (1270)
Healthcare (3535)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5834)
Job creations (2050)
Job search strategy (372)
Layoffs (168)
Legal (3414)
Lung cancer (55)
Manufacturing (110)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9570)
Metabolic disorders (192)
Neuroscience (473)
NextGen Class of 2024 (1580)
Non-profit (591)
Northern California (492)
Obesity (112)
Opinion (111)
Patents (65)
People (28557)
Pharmaceutical (67)
Phase I (7965)
Phase II (12953)
Phase III (11619)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3194)
Radiopharmaceuticals (116)
Rare diseases (108)
Real estate (2629)
Regulatory (9890)
Research institute (563)
Resumes & cover letters (55)
Southern California (490)
Startups (1626)
United States (4865)
Vaccines (114)
Weight loss (82)
Date
Today (2)
Last 7 days (110)
Last 30 days (770)
Last 365 days (12501)
2024 (12483)
2023 (14267)
2022 (19590)
2021 (20108)
2020 (19049)
2019 (14898)
2018 (11721)
2017 (13908)
2016 (13132)
2015 (15473)
2014 (12422)
2013 (10599)
2012 (11402)
2011 (11929)
2010 (10890)
Location
Africa (312)
Asia (19885)
Australia (2565)
California (1158)
Canada (676)
China (141)
Colorado (46)
Connecticut (48)
Europe (38954)
Florida (184)
Illinois (135)
Indiana (96)
Japan (53)
Kansas (52)
Maryland (173)
Massachusetts (993)
Minnesota (64)
New Jersey (497)
New York (325)
North Carolina (293)
Northern California (492)
Pennsylvania (315)
South America (499)
Southern California (490)
Texas (160)
Virginia (46)
Washington State (79)
262,324 Results for "tolero pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
COUR Pharmaceuticals Enters Collaboration and Licensing Agreement with Genentech to Develop and Commercialize Tolerogenic Therapy for the Treatment of an Autoimmune Disease
December 3, 2024
·
2 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Tolero Pharmaceuticals Presents Biomarker Identification Strategies for Investigational Agents Alvocidib and TP-1287 at AACR Virtual Meeting II 2020
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematologic and oncologic diseases, today presented findings
June 22, 2020
·
6 min read
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Press Releases
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
November 27, 2024
·
1 min read
Tolero Pharmaceuticals Submits Investigational New Drug Application for Experimental PKM2 Activator TP-1454
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its investigational small-molecule pyruvate kinase M2 isoform
May 19, 2020
·
4 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Business
Tolero Pharmaceuticals Joins The Leukemia & Lymphoma Society’s Groundbreaking Beat AML Master Clinical Trial for Patients with Acute Myeloid Leukemia
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that it has joined The Leukemia & Lymphoma Society (LLS) in the groundbreaking, collaborative Beat AML Master Clinical Trial for newly diagnosed patients 60 years of ag
March 26, 2020
·
7 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
1 of 26,233
Next